These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30417774)

  • 1. Advances in Antidiabetic Drugs Targeting Insulin Secretion.
    Ding Y; Li Y; Chen Q; Niu B
    Curr Pharm Des; 2018; 24(34):3990-3997. PubMed ID: 30417774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes area patent participation analysis - part II: years 2011-2016.
    Boehm M; Crawford M; Moscovitz JE; Carpino PA
    Expert Opin Ther Pat; 2018 Feb; 28(2):111-122. PubMed ID: 29140125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New oral antidiabetic agents].
    Doi K
    Nihon Rinsho; 1990 Dec; 48 Suppl():962-73. PubMed ID: 2128351
    [No Abstract]   [Full Text] [Related]  

  • 4. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats.
    Matsumoto K; Yoshitomi T; Ishimoto Y; Tanaka N; Takahashi K; Watanabe A; Chiba K
    J Pharmacol Exp Ther; 2018 Dec; 367(3):509-517. PubMed ID: 30217957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
    Baretić M; Troskot R
    Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin analogs and new oral antidiabetic drugs].
    Koivisto V
    Duodecim; 1999; 115(20):2197-202. PubMed ID: 11973922
    [No Abstract]   [Full Text] [Related]  

  • 8. The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade.
    Xu Q; Wang L; Luo J; Shi D
    Curr Drug Targets; 2018; 19(1):55-69. PubMed ID: 28270085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on Molecular Mechanism of Flavonoids as Antidiabetic Agents.
    Jasmin ; Jaitak V
    Mini Rev Med Chem; 2019; 19(9):762-786. PubMed ID: 30588881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria as potential targets in antidiabetic therapy.
    Moreira PI; Oliveira CR
    Handb Exp Pharmacol; 2011; (203):331-56. PubMed ID: 21484578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the cardiovascular risk with non-insulin antidiabetic drugs.
    Athyros VG; Imprialos K; Stavropoulos K; Sahinidis A; Doumas M
    Expert Opin Drug Saf; 2019 Mar; 18(3):241-251. PubMed ID: 30810055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic agents: past, present and future.
    Mehanna A
    Future Med Chem; 2013 Mar; 5(4):411-30. PubMed ID: 23495689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents].
    Nagashima K; Inagaki N
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):737-41. PubMed ID: 19472523
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity.
    Yaribeygi H; Sathyapalan T; Sahebkar A
    Life Sci; 2019 Oct; 234():116776. PubMed ID: 31425698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism.
    Meneses MJ; Silva BM; Sousa M; Sá R; Oliveira PF; Alves MG
    Curr Pharm Des; 2015; 21(25):3606-20. PubMed ID: 26166608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological agents that directly modulate insulin secretion.
    Doyle ME; Egan JM
    Pharmacol Rev; 2003 Mar; 55(1):105-31. PubMed ID: 12615955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion.
    Kogure R; Toyama K; Hiyamuta S; Kojima I; Takeda S
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):58-63. PubMed ID: 22079287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.